HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog).

AbstractAIMS:
The use of insulin lispro in pregnancy has not been systematically investigated despite its increasing use. Pooled data from seven centres with experience in the use of insulin lispro were accumulated to evaluate pregnancy outcome in women with Type 1 diabetes.
METHODS:
Seven units with specialist obstetric diabetes services were recruited to describe their total experience with insulin lispro in pregnancy. Outcomes with respect to the rate of miscarriage, congenital abnormality, perinatal mortality and maternal parameters were recorded in a standardized format.
RESULTS:
Outcomes on 71 babies from 76 pregnancies were documented. There were six (7.8%) early miscarriages. All 71 babies were liveborn with a mean gestational age of 37.2 weeks, and median birthweight of 3230 g. Seven babies weighed > 4 kg. There were four congenital abnormalities (5.6%). There was a 72% increase in the mean insulin dose (0.75-1.29 IU/kg per day). Maternal glycaemic control improved throughout pregnancy. No women developed retinopathy de novo during pregnancy and six with established retinopathy required laser therapy during pregnancy.
CONCLUSIONS:
The use of insulin lispro in Type 1 diabetes during pregnancy results in outcomes comparable to other large studies of diabetic pregnancy.
AuthorsE A Masson, J E Patmore, P D Brash, M Baxter, G Caldwell, I W Gallen, P A Price, P A Vice, J D Walker, S W Lindow
JournalDiabetic medicine : a journal of the British Diabetic Association (Diabet Med) Vol. 20 Issue 1 Pg. 46-50 (Jan 2003) ISSN: 0742-3071 [Print] England
PMID12519319 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Hypoglycemic Agents
  • Insulin
  • Insulin Lispro
Topics
  • Adult
  • Diabetes Mellitus, Type 1 (complications, drug therapy)
  • Female
  • Humans
  • Hypoglycemic Agents (therapeutic use)
  • Insulin (analogs & derivatives, therapeutic use)
  • Insulin Lispro
  • Pregnancy
  • Pregnancy Outcome
  • Pregnancy in Diabetics (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: